title: [Second line chemotherapy of carcinoma of the ovary. Current approaches].
abstract: In the present work, on the basis of the most recent knowledges, the Authors analyse and discuss the pharmacological and clinical aspects of the different types of second-line chemotherapeutical treatment for refractory ovarian cancer (standard single agent chemotherapy in high-dose schedules, new investigational anticancer agents, multidrugs chemotherapy, intraperitoneal chemotherapy).
authors.forename: F
authors.initials: F
authors.lastname: Sesti
authors.forename: L
authors.initials: L
authors.lastname: Mantenuto
authors.forename: G
authors.initials: G
authors.lastname: Ciancaglini
authors.forename: E
authors.initials: E
authors.lastname: Zupi
authors.forename: S
authors.initials: S
authors.lastname: Terenzi
authors.forename: E
authors.initials: E
authors.lastname: Piccione
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Chemioterapia di seconda linea del carcinoma ovarico. Orientamenti attuali.